Strengths and weaknesses of the acute care systems in the United Kingdom and the Netherlands: what can we learn from each other?

od Marjolein N. T. Kremers, Prabath W. B. Nanayakkara, Marcel Levi, Derek Bell, Harm R. Haak
Izdano 2019-07-01

EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity

od Rebecca V. Steenaard, Marieke Rutjens, Madeleine H. T. Ettaieb, Max M. van Noesel, Harm R. Haak
Izdano 2022-04-01

Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma

od Claudia Siebert, Denis Ciato, Denis Ciato, Masanori Murakami, Ludwig Frei-Stuber, Luis Gustavo Perez-Rivas, José Luis Monteserin-Garcia, Svenja Nölting, Julian Maurer, Annette Feuchtinger, Axel K. Walch, Harm R. Haak, Harm R. Haak, Harm R. Haak, Jérôme Bertherat, Massimo Mannelli, Martin Fassnacht, Esther Korpershoek, Martin Reincke, Günter K. Stalla, Günter K. Stalla, Constanze Hantel, Constanze Hantel, Felix Beuschlein, Felix Beuschlein
Izdano 2019-07-01

Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients

od Annika M. A. Berends, Mathieu S. Bolhuis, Ilja M. Nolte, Edward Buitenwerf, Thera P. Links, Henri J. L. M. Timmers, Richard A. Feelders, Elisabeth M. W. Eekhoff, Eleonora P. M. Corssmit, Peter H. Bisschop, Harm R. Haak, Ron H. N. van Schaik, Samira el Bouazzaoui, Bob Wilffert, Michiel N. Kerstens
Izdano 2022-04-01